Clinical Evidence: Thyroid RFA, Endoluminal RFA, and Fibroid RFA

Commitment to impactful evidence

The science behind evidence-based care

STARmed supports the generation of high-quality clinical evidence through collaborative research initiatives. We work with clinicians, hospitals, and medical societies to uncover the benefits of STARmed technology. We’re proud to accomplish this goal while maintaining a patient-centric mindset.

Browse the select articles below to explore the efficacy of RFA for thyroid nodules, endoluminal indications, and fibroids.

STARmed Thyroid RFA Treatment Clinical Evidence

STARmed technology is the most used device by Key Opinion Leaders around the world. It’s frequently utilized to develop procedure standards for thyroid RFA.

To date, more than 160 articles have been published with STARmed technology. This research proves the efficacy of STARmed Thyroid RFA treatment in terms of volume reduction rate, symptom relief, cosmetic score, and quality of life.

Learn more about the efficacy of the RFA procedure for thyroid nodules, liver malignancies, and more below.

2022 An international multidisciplinary consensus statement: Radiofrequency ablation and related ultrasound-guided ablation technologies for the treatment of benign and malignant thyroid disease

SEE THE STUDY

2022 Efficacy and Safety of Radiofrequency Ablation of Thyroid Nodules: A Multi-institutional Prospective Cohort Study

SEE THE STUDY

2022 Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy

SEE THE STUDY

2022 Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial

SEE THE STUDY

Endoluminal RFA Clinical Evidence

Endoluminal Radiofrequency ablation (RFA) is a well-established treatment for several benign, premalignant, and malignant disorders with emerging indications and applications for endoluminal RFA. RFA has produced promising outcomes in patients with a variety of biliary and pancreatic conditions.

2022 Radiofrequency ablation in the management of primary hepatic and biliary tumors

SEE THE STUDY

2021 Feasibility and Safety of Endoluminal Radiofrequency Ablation as a Rescue Treatment for Bilateral Metal Stent Obstruction Due to Tumor Ingrowth in the Hilum: A Pilot Study

SEE THE STUDY

2021 The Safety of Radiofrequency Ablation Using a Novel Temperature-Controlled Probe for the Treatment of Residual Intraductal Lesions after Endoscopic Papillectomy

SEE THE STUDY

2019 The safety of newly developed automatic temperature- controlled endobiliary radiofrequency ablation system for malignant biliary strictures: A prospective multicenter study

SEE THE STUDY

Put the Research to Work for Your Patients

Are you interested in implementing thyroid RFA treatment into your clinical practice? We are ready to help!

Reach out with your inquiry using our convenient contact form. Our representatives will respond to your online inquiry within 48 hours. If you need a response during the same business day, call STARmed America at 323-692-0028.